Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Histiocytosis, Langerhans-Cell × Sunitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 64 Breast Neoplasms 20 Kidney Neoplasms 19 Gastrointestinal Stromal Tumors 16 Neoplasms 15 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 9 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Brain Neoplasms 7 Colorectal Neoplasms 6 Neuroendocrine Tumors 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Liver Neoplasms 4 Thyroid Cancer, Papillary 3 Sarcoma 3 Pancreatic Neoplasms 3 Leukemia, Myelomonocytic, Chronic 3 Kidney Diseases 3 Glioblastoma 3 Esophageal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Astrocytoma 3 Adenoma, Islet Cell 3 Adenocarcinoma, Follicular 3

Interventions

X-Rays 5 Phantoms, Imaging 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Biopsy 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 Vemurafenib 2 LY3023414 2 trametinib 1 thymoglobulin 1 fludarabine 1 ensartinib 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Rituximab 1 Pharmacogenomic Variants 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡